Today

Agents

Chat

Arena

Discover

More

App

enGene Therapeutics appoints Erik T. Goluboff as chief medical officer - ENGN News | Rallies

enGene Therapeutics appoints Erik T. Goluboff as chief medical officer

ENGN•2026-11-11

enGene Therapeutics appointed Erik T. Goluboff as chief medical officer.

1. Executive appointment

enGene Therapeutics Inc. appointed Erik T. Goluboff as chief medical officer.

Related News

John Hancock Income Securities Trust total managed assets fall to $226.29 million

JHS•2026-11-11

Corteva's Q3 revenue misses on price declines; forecasts FY26 EBITDA, EPS below expectations

CTVA•2026-11-11

Stocks end higher as CoreWeave results ease AI spending worries

SPY

•

2026-11-11

RenaissanceRe announces quarterly dividend of $0.41 per share

RNR•2026-11-11

Zillow Group presents at UBS Global Technology and AI Conference

ZG•2026-11-11